Search for the second Peutz-Jeghers syndrome locus: exclusion of the STK13, PRKCG, KLK10, and PSCD2 genes on chromosome 19 and the STK11IP gene on chromosome 2Buchet-Poyau K. · Mehenni H. · Radhakrishna U. · Antonarakis S.E.
Division of Medical Genetics, Geneva University Medical School, and University Hospitals, Geneva (Switzerland)
Pathogenic mutations in the serine/threonine kinase STK11 (alias LKB1) cause Peutz-Jeghers syndrome (PJS) in most affected individuals. However, in a considerable number of PJS-patients mutations cannot be detected in STK11 suggesting genetic heterogeneity. One PJS family without STK11 mutations (PJS07) has previously been described with significant evidence for linkage to a second potential PJS locus on 19q13.3→q13.4. In this study we investigated candidate genes within markers D19S180 and D19S254, since multipoint linkage analysis yielded significant LOD scores for this region in this family. Four genes in the region (cytohesin 2: PSCD2, kallikrein 10: KLK10, protein kinase C gamma: PRKCG, and serine/threonine kinase 13: STK13) potentially involved in growth inhibitory pathways or in the pathophysiology of can- cer, were considered as candidates. We first determined the genomic structure of the PSCD2 and PRKCG genes, and performed mutation analysis of all exons and exon-intron junctions of the four genes, in the PJS07 family. No pathogenic mutation was identified in these four genes in affected individuals. A very rare polymorphism resulting in a conserved amino acid change Lys to Arg was found in PSCD2. These data provide considerable evidence for exclusion of these four genes as candidates for the second locus on 19q13.3→q13.4 in PJS. Finally, we also excluded the recently identified STK11-interacting protein gene (STK11IP, alias LIP1) mapped in 2q36 as candidate for PJS in the PJS07 family, although this could be a good candidate in other non-STK11/LKB1 families.
© 2002 S. Karger AG, Basel
Request reprints from Stylianos E. Antonarakis, Division of Medical Genetics
Geneva University Medical School, 1 rue Michel Servet
1211 Geneva 4 (Switzerland); telephone: (+41) 22 702 5708
fax: (+41) 22 702 5706; e-mail: Stylianos.Antonarakis@medecine.unige.ch
Supported by grants from the “Ligue Suisse contre le Cancer” and funds from the University and the Cantonal Hospital of Geneva. K.B. was partially supported by the French “Association pour la Recherche contre le Cancer”.
Received: Received 15 July 2002;
manuscript accepted 7 August 2002.
Number of Figures : 3, Number of Tables : 3, Number of References : 34
Cytogenetic and Genome Research
Formerly ‘Cytogenetics and Cell Genetics’
Vol. 97, No. 3-4, Year 2002 (Cover Date: 2002)
Journal Editor: H.P. Klinger, Bronx, N.Y.; M. Schmid, Würzburg
ISSN: 1424–8581 (print), 1424–859X (Online)
For additional information: http://www.karger.com/journals/cgr